| NLPHL-DLBCL (n = 33) | Conventional DLBCL (n = 41) |
---|---|---|
Patients with simultaneous involvement by NLPHL and DLBCL | 26 | - |
Patients with sequential involvement by NLPHL and DLBCL | 7 | - |
Median patient age (range) | 50 (19– 78) | 69 (19– 93) |
male gender (%) | 85 | 100* |
Biopsy site | Â | Â |
- axillary | 12 (36%) | 4 (10%) |
- cervical/ supraclavicular | 9 (27%) | 26 (63%) |
- abdominal/ mesenteric LN /bowel | 8 (24%) | 5 (12%) |
- inguinal | 4 (12%) | 1 (2%) |
- mediastinal/ retroperitoneal | 0 | 3 (7%) |
- other | 0 | 2 (5%) |
Splenic involvement | 30% | 5% |
Stage** | Â | Â |
- I | 2 (9%) | 7 (17%) |
- II | 4 (18%) | 12 (29%) |
- III | 6 (27%) | 12 (29%) |
- IV | 10 (45%) | 10 (24%) |